Analysis of CYP27B1 in multiple sclerosis

Journal of Neuroimmunology

Volumn 266, Issue 1-2, 2014, Pages 64-66

  Ross, Jay P ^a   Bernales, Cecily Q ^a   Lee, Joshua D ^a   Sadovnick, A Dessa ^a   Traboulsee, Anthony L ^a   Vilariño Güell, Carles ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CYP27B1; Linkage; Multiple sclerosis; Mutation

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; CYP27B1 GENE; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUTATOR GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 84891488656     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.11.006     Document Type: Article

References (16)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. ANZgene (Australia and New Zealand Multiple Sclerosis Genetics Consortium) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41:824-828.
3. Ban M., Caillier S., Mero I.L., Myhr K.M., Celius E.G., Aarseth J., Torkildsen O., Harbo H.F., Oksenberg J., Hauser S.L., Sawcer S., Compston A. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann. Neurol. 2013, 73:430-432.
4. Barizzone N., Pauwels I., Luciano B., Franckaert D., Guerini F.R., Cosemans L., Hilven K., Salviati A., Dooley J., Danso-Abeam D., di Sapio A., Cavalla P., Decallonne B., Mathieu C., Liston A., Leone M., Dubois B., D'Alfonso S., Goris A. No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Ann. Neurol. 2013, 73:433-437.
5. Chartier-Harlin M.C., Dachsel J.C., Vilarino-Guell C., Lincoln S.J., Lepretre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destee A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am. J. Hum. Genet. 2011, 89:398-406.
6. Cortes A., Field J., Glazov E.A., Hadler J., Stankovich J., Brown M.A. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Hum. Mol. Genet. 2013, 22:2283-2292.
7. Keeling B.H., Vilarino-Guell C., Ross O.A., Wszolek Z.K., Uitti R.J., Farrer M.J. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci. Lett. 2009, 461:74-75.
8. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4:1073-1081.
9. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
10. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
11. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
12. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
13. Ramagopalan S.V., Dyment D.A., Cader M.Z., Morrison K.M., Disanto G., Morahan J.M., Berlanga-Taylor A.J., Handel A., De Luca G.C., Sadovnick A.D., Lepage P., Montpetit A., Ebers G.C. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann. Neurol. 2011, 70:881-886.
14. Reinthaler E., Machetanz G., Hotzy C., Reindl M., Fazekas F., Kristoferitsch W., Berger T., Schmied C., Zimprich A. No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients. Mult. Scler. 2013, http://dx.doi.org/10.1177/1352458513498130 (in press).
15. Sadovnick A.D., Risch N.J., Ebers G.C. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Can. J. Neurol. Sci. 1998, 25:216-221. Canadian Collaborative Study Group.
16. Vilarino-Guell C., Wider C., Soto-Ortolaza A.I., Cobb S.A., Kachergus J.M., Keeling B.H., Dachsel J.C., Hulihan M.M., Dickson D.W., Wszolek Z.K., Uitti R.J., Graff-Radford N.R., Boeve B.F., Josephs K.A., Miller B., Boylan K.B., Gwinn K., Adler C.H., Aasly J.O., Hentati F., Destee A., Krygowska-Wajs A., Chartier-Harlin M.C., Ross O.A., Rademakers R., Farrer M.J. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 2009, 72:2024-2028.